From Russia with review [RSABE / ABEL]

posted by mittyri – Russia, 2019-12-04 11:29  – Posting: # 20917
Views: 956

(edited by mittyri on 2019-12-04 11:55)

Hi Helmut,

» Since three authors are members of the “Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation” (and the first one is the head of the department): Are the conclusions really a recommendation?

I would translate the sentence in the last paragraph before conclusion as:
Currently the discussions related to reference scaling modification are going on.
Conclusion says that it is just a review, not a recommendation.

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
20,255 posts in 4,263 threads, 1,398 registered users;
online 7 (0 registered, 7 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 12:20 CET

You should treat as many patients as possible with the new drugs
while they still have the power to heal.    Armand Trousseau

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5